 Immunoglobulin M
"Immunoglobulin M" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally being called a macroglobulin.
| Descriptor ID |
D007075
|
| MeSH Number(s) |
D12.776.124.486.485.114.619.574 D12.776.124.790.651.114.619.574 D12.776.377.715.548.114.619.574
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Immunoglobulin M".
Below are MeSH descriptors whose meaning is more specific than "Immunoglobulin M".
This graph shows the total number of publications written about "Immunoglobulin M" by people in this website by year, and whether "Immunoglobulin M" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 3 | 2 | 5 | | 1996 | 1 | 1 | 2 | | 1997 | 1 | 3 | 4 | | 1998 | 0 | 2 | 2 | | 1999 | 1 | 1 | 2 | | 2000 | 0 | 5 | 5 | | 2001 | 1 | 2 | 3 | | 2002 | 1 | 3 | 4 | | 2003 | 1 | 0 | 1 | | 2004 | 0 | 3 | 3 | | 2005 | 2 | 1 | 3 | | 2006 | 0 | 3 | 3 | | 2007 | 1 | 4 | 5 | | 2008 | 1 | 1 | 2 | | 2009 | 2 | 5 | 7 | | 2010 | 1 | 4 | 5 | | 2011 | 0 | 3 | 3 | | 2012 | 1 | 2 | 3 | | 2013 | 3 | 3 | 6 | | 2014 | 1 | 1 | 2 | | 2015 | 3 | 3 | 6 | | 2016 | 1 | 2 | 3 | | 2017 | 2 | 7 | 9 | | 2018 | 2 | 2 | 4 | | 2019 | 1 | 4 | 5 | | 2020 | 1 | 7 | 8 | | 2021 | 3 | 6 | 9 | | 2022 | 0 | 8 | 8 | | 2023 | 1 | 6 | 7 | | 2024 | 1 | 5 | 6 | | 2025 | 1 | 3 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Immunoglobulin M" by people in Profiles.
-
Moreno DF, Nadeu F, Brasó-Maristany F, Vaqué S, Paz S, Mañé J, Cardús O, Medina E, Lozano E, Rodríguez-Lobato LG, de Daniel A, Tovar N, Cibeira MT, Bladé J, Rosiñol L, Prat A, Colomer D, Fernández de Larrea C. Genomic and immune profiling of prognostic risk groups in IgM gammopathy reveals novel biomarkers beyond MYD88 L265P. Front Immunol. 2025; 16:1604089.
-
Petr V, Tichanek F, Liu SL, Poppelaars F, Renner B, Laskowski J, Purohit S, Zhao M, Jalal D, Heeger PS, Thurman JM. Pretransplant natural antibody levels identify a subset of deceased donor kidney transplant recipients that benefit from infliximab induction. Am J Transplant. 2025 Oct; 25(10):2173-2181.
-
Dadelahi A, Walker BS, Banerjee D, Mahler M, Saadalla A, Nandakumar V. Is the 99th Percentile Cutoff Still Relevant? A Single-Center Assessment of Different Thresholds for Diagnosing Antiphospholipid Syndrome. J Appl Lab Med. 2025 May 02; 10(3):605-618.
-
Wheeler EA, Lenhart-Pendergrass PM, Rysavy NM, Poch KR, Caceres SM, Calhoun KM, Serban KA, Nick JA, Malcolm KC. Divergent host humoral innate immune response to the smooth-to-rough adaptation of Mycobacterium abscessus in chronic infection. Front Cell Infect Microbiol. 2025; 15:1445660.
-
Hossain F, Ghosh P, Chowdhury FR, Basher A, Ahsan HMN, Khan AH, Shumu SJ, Jahan T, Roy CK, Arefin AKMN, Khanam F, Rahat MA, Chowdhury R, Uddin MR, Shomik MS, Maruf S, Rashid MU, Sagar SK, Mithila NT, Chowdhury MAA, Kamal M, Sharfaraz A, Ghosh D, Chowdhury A, Chowdhury AH, Hossain Z, Arefeen F, Islam MS, Rahman SMM, Al-Amin TM, Rashid A, Shukla KK, Roy S, Rana MS, Hossain MS, Siegel M, Wahed AAE, Mondal D. Evaluating a rapid molecular assay in a mobile laboratory for improved diagnosis of dengue in Bangladesh. Int J Infect Dis. 2025 Jan; 150:107299.
-
Tiamiyu AB, Adegbite OA, Freides O, Frndak S, Mohammed SS, Broach E, Lombardi K, Anyebe V, Akiga R, Okeke NC, Feyisayo JE, Ugwuezumba O, Akinde C, Osuji A, Agu N, Analogbei T, Ekweremadu C, Bartolanzo D, Prins P, Fan Y, Emekaili D, Abah F, Chiwetelu V, Dike P, Isaiah E, Ayogu M, Ogunkelu E, Agbaim UC, Bukunmi A, Adamu Y, Mebrahtu T, Zuppe A, Johnston M, Modjarrad K, Meri H, Parker Z, Akinwale E, McCauley MD, Schluck G, King DB, Eller LA, Okeji N, Ayemoba OR, Collins ND, Iroezindu MO, Hakre S. Seroprevalence and risk factors for Lassa virus infection in South-West and North-Central Nigeria: a community-based cross-sectional study. BMC Infect Dis. 2024 Oct 08; 24(1):1118.
-
Tebo AE, Willis R, Nwosu A, Bashleben C, Fox DA, Linden MA, Karlon WJ. Reporting and Establishment of Reference Intervals for Antiphospholipid Antibody Immunoassays: A Survey of Participants in the College of American Pathologists Proficiency Testing Program. Arch Pathol Lab Med. 2024 Jun 01; 148(6):686-693.
-
Li Y, Ettah U, Jacques S, Gaikwad H, Monte A, Dylla L, Guntupalli S, Moghimi SM, Simberg D. Optimized Enzyme-Linked Immunosorbent Assay for Anti-PEG Antibody Detection in Healthy Donors and Patients Treated with PEGylated Liposomal Doxorubicin. Mol Pharm. 2024 Jun 03; 21(6):3053-3060.
-
Mohyuddin H, Laffon B, Teixeira JP, Costa S, Teixeira-Gomes A, P?saro E, Constantine N, Dagdag A, Ortmeyer HK, Tizenberg B, Afram L, Yen P, Marano C, Lowry CA, Hoisington AJ, RachBeisel JA, Valdiglesias V, Lema-Arranz C, Fern?ndez-Bert?lez N, Maseda A, Mill?n-Calenti JC, Kovacs EJ, Gostner JM, Fuchs D, Brenner LA, Lorenzo-L?pez L, Postolache TT. Toxoplasma gondii IgG Serointensity Is Positively Associated With Frailty. J Gerontol A Biol Sci Med Sci. 2024 03 01; 79(3).
-
Saadalla A, Nandakumar V. Anti-phosphatidyl-serine/prothrombin (aPS/PT) antibodies are superior predictors of LAC presence and APS diagnoses: A single center study. Clin Chim Acta. 2024 Feb 01; 554:117761.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|